Nautilus Biotechnology
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2016
- Employees
- 150
- Stage
- Public
- Total raised
- $200M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $200M · Jun 2021 SEC Form D
- Founders
- Sujal Patel, Parag Mallick, PhD
Sujal Patel - Founder and CEO at Nautilus Biotechnology
Sujal Patel is Founder and CEO of Nautilus Biotechnology, a life sciences company creating a large-scale, single-molecule platform for quantifying and unlocking the complexity of the human proteome, with the goal of enabling fundamental advancements across human health and medicine. With nearly 20 years of executive leadership experience driving innovation for high-growth companies, Sujal is a successful entrepreneur, investor, and philanthropist who founded and served as CEO of Isilon Systems, an enterprise data storage company. After completing one of the most successful initial public offerings of 2006, Isilon was acquired by EMC in 2010 for $2.6 billion. See omnystudio.com/listener for…
How SPACs are shaking up Seattle's startup scene
An online marketplace that helps to facilitate trade between marijuana sellers and buyers will soon see its own stock traded on the Nasdaq. Another that connects pet owners with walkers, boarders and other caregivers just posted its first earnings as a publicly traded company. And a 3-year-old Redmond-based biotech company with a mere 25 employees just raised $80 million its stock market debut. SPACs are shaking up Seattle's startup scene. On this episode of the GeekWire Podcast, we examine how special purpose acquisition companies are turning startups into publicly traded stocks at a rapid clip. The SPAC phenomenon is giving…
People
-
Sujal Patel Executive, Co-founder and CEO, Executive Officer, Director
